Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Reviewing Osteoporosis Drugs for Esophageal Cancer Risk
FDA Reviewing Osteoporosis Drugs for Esophageal Cancer Risk
FDA Reviewing Osteoporosis Drugs for Esophageal Cancer Risk
Submitted by
admin
on July 21, 2011 - 2:01pm
Source:
Bloomberg
News Tags:
FDA
osteoporosis
esophageal cancer
Roche
Novartis
bisphosphonates
Merck
Boniva
Reclast
Fosamax
Headline:
FDA Reviewing Osteoporosis Drugs for Esophageal Cancer Risk
Do Not Allow Advertisers to Use My Personal information
